Susquehanna International Group’s Co-Diagnostics CODX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-390
Closed -$14.6K 12316
2024
Q3
$14.6K Buy
+390
New +$15K ﹤0.01% 11678
2023
Q2
Sell
-1,187
Closed -$52.7K 12189
2023
Q1
$52.7K Buy
1,187
+137
+13% +$11K ﹤0.01% 11680
2022
Q4
$79.4K Sell
1,050
-4,667
-82% -$437K ﹤0.01% 11128
2022
Q3
$551K Sell
5,717
-8,010
-58% -$1.12M ﹤0.01% 8225
2022
Q2
$2.31M Buy
13,727
+4,704
+52% +$715K ﹤0.01% 4614
2022
Q1
$1.67M Buy
9,023
+5,173
+134% +$1.07M ﹤0.01% 5873
2021
Q4
$1.03M Sell
3,850
-983
-20% -$258K ﹤0.01% 7214
2021
Q3
$1.41M Buy
4,833
+2,356
+95% +$688K ﹤0.01% 6650
2021
Q2
$613K Sell
2,477
-290
-10% -$74.5K ﹤0.01% 9086
2021
Q1
$792K Sell
2,767
-7,480
-73% -$2.99M ﹤0.01% 8333
2020
Q4
$2.86M Buy
10,247
+3,314
+48% +$1.23M ﹤0.01% 4385
2020
Q3
$2.83M Sell
6,933
-9,180
-57% -$4.72M ﹤0.01% 3974
2020
Q2
$9.35M Buy
16,113
+11,760
+270% +$5.37M ﹤0.01% 2211
2020
Q1
$995K Buy
+4,353
New +$755K ﹤0.01% 5416

Other funds holding CODX

Susquehanna International Group's CODX Position: Q1 2026 in Review

Susquehanna International Group sold out of Co-Diagnostics (CODX) in Q1 2026, closing a stake of 1,642 shares — an estimated $8.3K sold.

Susquehanna International Group first reported a position in CODX in Q1 2020 and held it in 24 quarters. The position peaked at $4.13M in Q3 2021. 14 funds tracked by Wall St. Rank hold CODX as of Q1 2026.

  • Susquehanna International Group reported no remaining Co-Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 1,642 Co-Diagnostics shares in Q1 2026, an estimated $8.3K.
  • Susquehanna International Group first reported a position in Co-Diagnostics in Q1 2020 and held it in 24 quarters.
  • Susquehanna International Group's Co-Diagnostics position peaked at $4.13M in Q3 2021.
  • 14 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.